DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Almorexant is an investigational drug.
There have been 7 clinical trials for Almorexant. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2008.
The most common disease conditions in clinical trials are Sleep Initiation and Maintenance Disorders, Restless Legs Syndrome, and Psychomotor Agitation. The leading clinical trial sponsors are Midnight Pharma, LLC, Northern California Institute of Research and Education, and U.S. Army Medical Research and Materiel Command.
Recent Clinical Trials for Almorexant
|Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant||Diego Garcia-Borreguero, Paseo de la Habana 151, Madrid 28036, SPAIN||Phase 2|
|Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant||Rocío Prieto Pérez||Phase 2|
|Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206||Actelion||Phase 1|